Key Principles in Safely Prescribing Bispecific Antibodies in Heavily Pretreated Patients With Multiple Myeloma

Date: June 8, 2023

Time: 03:00PM - 03:30PM

You must be registered to participate!

  • Josh Epworth, MSN, ARNP, Nurse Practitioner, Hematology Oncology, Fred Hutchinson Cancer Center

Join Josh Epworth, MSN, ARNP, of Fred Hutchinson Cancer Center as he talks about the AP role in managing patients heavily pretreated for multiple myeloma as they receive bispecific antibody therapy. Drawing on several interesting cases, Josh will discuss the challenge of selecting continued treatment options for these patients and coordinating their care, as well as how to manage potentially serious adverse events that can be associated with this treatment.

Access the cases and polling questions here